Related Experiment Video
Updated: Jul 8, 2026
04:20
Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Gene expression in early stage cervical cancer
Petra Biewenga1, Marrije R Buist, Perry D Moerland
1Department of Gynaecologic Oncology, Academic Medical Center, Meibergdreef 9, 1100 AZ Amsterdam, The Netherlands. p.biewenga@amc.uva.nl
Gynecologic Oncology
|January 15, 2008
Summary
Gene expression profiling cannot accurately predict lymph node metastasis in early cervical cancer. However, it effectively distinguishes cancer from healthy tissue, highlighting potential for diagnostic markers.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Pelvic lymph node metastasis is a critical prognostic factor in early-stage cervical cancer.
- Accurate pre-operative detection of lymph node involvement remains a clinical challenge.
Purpose of the Study:
- To evaluate gene expression profiling for predicting lymph node metastasis in early-stage squamous cell cervical cancer.
- To compare gene expression patterns between cervical cancer and normal cervical tissues.
Main Methods:
- Analysis of tumor samples from 35 early-stage cervical cancer patients (16 with lymph node metastasis, 19 without) and 5 normal cervical tissues.
- Investigated differential gene expression and built predictive classifiers using a multiple validation strategy.
Main Results:
- Five genes (BANF1, LARP7, SCAMP1, CUEDC1, PEBP1) showed differential expression between lymph node-positive and negative tumors.
- Mean accuracy for predicting lymph node status was 64.5% (95% CI: 40-90%).
- Gene expression profiling achieved 99.5% accuracy (95% CI: 90-100%) in differentiating early-stage cervical cancer from healthy tissue.
Conclusions:
- Gene expression profiling did not yield accurate prediction of lymph node status in early-stage cervical cancer.
- Further replication studies are necessary to validate the identified differentially expressed genes.
- Gene expression profiling demonstrates high accuracy in distinguishing cervical cancer from normal tissue.
